Effect of stimulant medications for attention-deficit/hyperactivity disorder on later substance use and the potential for stimulant misuse, abuse, and diversion
- PMID: 18307377
Effect of stimulant medications for attention-deficit/hyperactivity disorder on later substance use and the potential for stimulant misuse, abuse, and diversion
Abstract
The objective of this article is to review literature about the effects of stimulant therapy on substance use disorders and the potential for misuse and diversion of stimulants. We reviewed published literature relevant to these objectives, and studies were selected if they were published or accepted for publication in peer-reviewed journals. Prospective longitudinal studies show that attention-deficit/hyperactivity disorder (ADHD) is a risk factor for subsequent substance use disorders. These studies also suggest that ADHD pharmacotherapy in childhood reduces the risk for substance use disorders. Misuse and diversion of prescribed stimulants occur among a minority of ADHD patients, especially those with conduct or substance use disorders. Long-acting stimulants may be less likely to be misused or diverted.
Similar articles
-
Managing attention-deficit/hyperactivity disorder in the presence of substance use disorder.J Clin Psychiatry. 2007;68 Suppl 11:23-30. J Clin Psychiatry. 2007. PMID: 18307378 Review.
-
Pharmacotherapy for attention-deficit/hyperactivity disorder (ADHD) decreases the risk for substance abuse: findings from a longitudinal follow-up of youths with and without ADHD.J Clin Psychiatry. 2003;64 Suppl 11:3-8. J Clin Psychiatry. 2003. PMID: 14529323
-
Childhood stimulant treatment and risk for later substance abuse.J Clin Psychiatry. 2003;64 Suppl 11:19-23. J Clin Psychiatry. 2003. PMID: 14529326
-
Does stimulant treatment lead to substance use disorders?J Clin Psychiatry. 2003;64 Suppl 11:9-13. J Clin Psychiatry. 2003. PMID: 14529324
-
The potential for misuse and abuse of medications in ADHD: a review.Postgrad Med. 2014 Sep;126(5):64-81. doi: 10.3810/pgm.2014.09.2801. Postgrad Med. 2014. PMID: 25295651 Review.
Cited by
-
A comprehensive evaluation of adverse childhood experiences, social-emotional impairments, and neurodevelopmental disorders in cannabis-use disorder: Implications for clinical practice.Eur Psychiatry. 2023 Sep 13;66(1):e77. doi: 10.1192/j.eurpsy.2023.2436. Eur Psychiatry. 2023. PMID: 37702087 Free PMC article.
-
Advances in understanding and treating ADHD.BMC Med. 2011 Jun 10;9:72. doi: 10.1186/1741-7015-9-72. BMC Med. 2011. PMID: 21658285 Free PMC article. Review.
-
Diagnosing and treating attention-deficit/hyperactivity disorder in adults.World Psychiatry. 2008 Oct;7(3):131-6. doi: 10.1002/j.2051-5545.2008.tb00179.x. World Psychiatry. 2008. PMID: 18836579 Free PMC article.
-
Psychoactive substance use in patients diagnosed with attention-deficit/hyperactivity disorder: an exploratory study.Front Psychiatry. 2023 Jul 11;14:1184023. doi: 10.3389/fpsyt.2023.1184023. eCollection 2023. Front Psychiatry. 2023. PMID: 37496681 Free PMC article.
-
Use of stimulants to treat cocaine and methamphetamine abuse.Curr Psychiatry Rep. 2008 Oct;10(5):385-91. doi: 10.1007/s11920-008-0062-x. Curr Psychiatry Rep. 2008. PMID: 18803911 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical